Mechanisms underlying the negative growth hormone (GH) autofeedback on the GH-releasing effect of hexarelin in man

Metabolism: Clinical and Experimental

Volumn 46, Issue 1, 1997, Pages 83-88

  Arvat, Emanuela ^b   Di Vito, Lidia ^b   Gianotti, Laura ^b   Ramunni, Josefina ^b   Boghen, Muni F ^b   Deghenghi, Romano ^b   Camanni, Franco ^b   Ghigo, Ezio ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HEXARELIN; SOMATOSTATIN;

ARTICLE; FEEDBACK SYSTEM; GROWTH HORMONE RELEASE; HYPOPHYSIS; HYPOTHALAMUS; NERVE CELL; PRIORITY JOURNAL;

EID: 0031033244     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90173-6     Document Type: Article

References (42)

1. Ghigo E: Neurotransmitter control of growth hormone secretion, in De la Cruz LF (ed): Regulation of Growth Hormone and Somatic Growth. Amsterdam, The Netherlands, Excerpta Medica, 1992, pp 103-120
2. Casanueva FF: Physiology of growth hormone secretion and action. Endocrinol Metab Clin North Am 21:483-517, 1992
3. Ross RJM, Tsagarakis S, Grossman A, et al: GH feedback occurs through modulation of hypothalamic somatostatin under cholinergic control: Studies with pyridostigmine and GHRH. Clin Endocrinol (Oxf) 27:727-733, 1987
4. Rosenbaum M, Loche S, Balzano S, et al: Short-term Met-hGH infusion inhibits somatotroph response to growth hormone releasing hormone (1-44). Metabolism 37:131-135, 1988
5. Rosenthal SM, Kaplan SL, Grumbach MM: Short term continuous intravenous infusion of growth hormone (GH) inhibits GH-releasing hormone-induced GH secretion: A time-dependent effect. J Clin Endocrinol Metab 68:1101-1105, 1989
6. Lanzi R, Tannenbaum GS: Time-dependent reduction and potentiation of growth hormone (GH) responsiveness to GH-releasing factor induced by exogenous GH: Role for somatostatin. Endocrinology 130:1822-1828, 1992
7. Torsello A, Panzeri G, Cermenati P, et al: Involvement of the somatostatin and cholinergic systems in the mechanism of growth hormone autofeedback regulation in the rat. J Endocrinol 117:273-281, 1988
8. Tannenbaum GS: Evidence for autoregulation of growth secretion via the central nervous system. Endocrinology 107:2117-2120, 1980
9. Massara F, Ghigo E, Molinatti P, et al: Potentiation of cholinergic tone by pyridostigmine bromide reinstates and potentiates the growth hormone responsiveness to intermittent administration of growth hormone-releasing factor in man. Acta Endocrinol (Copenh) 113:12-16, 1996
10. Kelijman M, Frohman L: β-Adrenergic modulation of growth hormone (GH) autofeedback on sleep-associated and pharmacologically induced GH secretion. J Clin Endocrinol Metab 69:1187-1193, 1989
11. Arosio M, Losa M, Bazzoni N, et al: Effects of propranolol on GH responsiveness to repeated GH-releasing hormone stimulation in normal subjects. Acta Endocrinol (Copenh) 122:1-5, 1990
12. Ghigo E, Arvat E, Valente F, et al: Arginine reinstates the growth hormone responsiveness to intermittent administration of growth hormone-releasing hormone in man. Neuroendocrinology 54:291-294, 1991
13. Arvat E, Ghigo E, Nicolosi M, et al: Galanin reinstates the growth hormone response to repeated growth hormone-releasing hormone administration in man. Clin Endocrinol (Oxf) 36:347-350, 1992
14. Bowers CY, Momany FA, Reynolds GA, et al: On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 114: 1537-1545, 1984
15. Bowers CY: GH releasing peptides. Structure and kinetics. J Pediatr Endocrinol 6:21-31, 1993
16. Deghenghi R, Boutignon F, Wuthrich P, et al: GH releasing properties of hexarelin (EP 23905). International Symposium on Growth Hormone II: Basic and Clinical Aspects. Tarpon Springs, FL, December 3-6, 1992, abstr p 31
17. Ghigo E, Arvat E, Gianotti L, et al: Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal and oral administration in man. J Clin Endocrinol Metab 78:693-698, 1994
18. Momany FA, Bowers CY, Reynolds GA, et al: Conformational energy studies and in vitro and in vivo activity data on growth hormone-releasing peptides. Endocrinology 114:1531-1537, 1984
19. Bowers CY, Reynolds GA, Durham D, et al: Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. J Clin Endocrinol Metab 70:975-978, 1990
20. Bowers CY, Sartor AO, Reynolds GA, et al: On the actions of the growth hormone-releasing hexapeptide, GHRP. Endocrinology 128: 2027-2035, 1991
21. Penalva A, Carballo A, Pombo M, et al: Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man. J Clin Endocrinol Metab 76:168-171, 1993
22. Arvat E, Gianotti L, Di Vito L, et al: Modulation of growth hormone-releasing activity of hexarelin in man. Neuroendocrinology 61:51-56, 1995
23. Badger TM, Millard WJ, McCormick GF, et al: The effects of growth hormone (GH)-releasing peptides on GH secretion in perifused pituitary cells of adult male rats. Endocrinology 115:1432-1438, 1984
24. Sartor O, Bowers CY, Chang D: Parallel studies of His-D-trp-ala-trp-D-phe-lys-NH2 and human pancreatic growth hormone-releasing factor-44-NH2 in rat primary pituitary cell monolayer culture. Endocrinology 116:952-957, 1985
25. Cheng K, Chan WWS, Barretto A Jr, et al: The synergistic effects of His-D-trp-ala-trp-D-phe-lys-NH2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3′,5′-monophosphate accumulation in rat primary pituitary cell culture. Endocrinology 124:2791-2798, 1989
26. Mallo F, Alvarez CV, Benitez L, et al: Regulation of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 (GHRP6)-induced GH secretion in the rat. Neuroendocrinology 57:247-251, 1992
27. Goth MI, Lyons CE, Canny BJ, et al: Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors. Endocrinology 130:939-944, 1992
28. Clark RG, Carlsson LMS, Trojnar J, et al: The effects of a growth hormone-releasing peptide and growth hormone-releasing factor in conscious and anaesthetized rats. J Neuroendocrinol 1:249-255, 1989
29. Guillaume V, Magnan E, Cataldi M, et al: Growth hormone (GH)-releasing hormone secretion stimulated by a new GH-releasing hexapeptide in sheep. Endocrinology 135:1073-1076, 1994
30. Dickson SL, Leng G, Robinson ICAF: Systemic administration of growth hormone-releasing peptide activates hypothalamic arcuate neurones. Neurosci Lett 53:303-307, 1993
31. Conley LK, Teik JA, Deghenghi R, et al: Mechanism of action of hexarelin and GHRP-6: Analysis of the involvement of GHRH and somatostatin in the rat. Neuroendocrinology 61:44-50, 1995
32. Fairhall KM, Mynett A, Robinson ICAF: Central effects of growth hormone-releasing hexapeptide (GHRP-6) on growth hormone release are inhibited by central somatostatin action. J Endocrinol 144:555-560, 1995
33. Codd EE, Shu AYL, Walker RF: Binding of a growth hormone releasing hexapeptide to specific hypothalamic and pituitary binding sites. Neuropharmacology 28:1139-1144, 1989
34. Sethumadavan K, Veeraragavan K, Bowers CY: Demonstration and characterization of the specific binding of growth hormone releasing peptide to rat anterior pituitary and hypothalamic membranes. Biochem Biophys Res Commun 178:31-37, 1991
35. Muccioli G, Ghe' C, Ghigo MC, et al: Presence of specific receptors for hexarelin, a GH releasing hexapeptide, in human brain and pituitary gland. International Symposium on Growth Factors in Endocrinology and Metabolism, Berlin, Germany, September 29-30, 1995, abstr p 110
36. Maccario M, Arvat E, Procopio M, et al: Metabolic modulation of the growth hormone-releasing activity of hexarelin in man. Metabolism 44:134-138, 1995
37. Massoud AF, Hindmarsh PC, Brook CGD: Hexarelin induced growth hormone release is influenced by exogenous growth hormone. Clin Endocrinol (Oxf) 43:617-621, 1995
38. Cappa M, Setzu S, Bernardini S, et al: Exogenous growth hormone administration does not inhibit the growth hormone response to hexarelin in normal men. J Endocririol Invest 18:762-766, 1995
39. Popovic V, Damjanovic S, Micic D, et al: Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: Evidence that GHRP-6 main action is exerted at the hypothalamic level. J Clin Endocrinol Metab 80:942-947, 1995
40. Conway S, McCann SM, Krulich L: On the mechanism of growth hormone autofeedback regulation: Possible role of somatostatin and growth hormone-releasing factor. Endocrinology 117:2284-2292, 1985
41. Clark RG, Carlsson LMS, Robinson ICAF: Growth hormone (GH) secretion in the conscious rat: Negative feedback of GH on its release. J Endocrinol 119:201-209, 1988
42. Chomczynski P, Downs TR, Frohman LA: Feedback regulation of growth hormone releasing hormone gene expression by growth hormone in rat hypothalamus. Mol Endocrinol 2:236-241, 1988